Physician profile
Wesley J Kai
NPI 1598853160
$10,481.69
in general payments reported to CMS, 2019-2025
20 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,600 · 2020: $2,948 · 2021: $940 · 2022: $1,282 · 2023: $1,081 · 2024: $592 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,691 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,690.97 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,056.15 | 2019-2020 | |
| Abbott Laboratories | $2,012.32 | 2019-2023 | Xience Skypoint |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $999.98 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $823.40 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $590.47 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $471.08 | 2021-2025 | Jardiance |
| Abiomed | $390.10 | 2022-2024 | Impella |
| Shockwave Medical, INC | $372.08 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $301.01 | 2019-2025 | Watchman Flx, General - Crm_crm, Resonate El Icd Vr |
| Medtronic, INC. | $291.10 | 2023-2025 | Selectsecure, Aurora Ev-Icd Mri Surescan |
| Bayer Healthcare Pharmaceuticals INC. | $269.68 | 2021-2024 | |
| Regeneron Pharmaceuticals, INC. | $207.62 | 2019 | |
| Janssen Scientific Affairs, LLC | $136.00 | 2023 | Xarelto |
| Baxter Healthcare | $127.67 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $124.99 | 2025 | Repatha |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $113.70 | 2019-2023 | Definity |
| Janssen Pharmaceuticals, INC | $111.61 | 2022 | |
| Cvrx, INC. | $37.98 | 2024 | Barostim Neo System |
| Acist Medical Systems, INC. | $23.59 | 2022 | |
| Alnylam Pharmaceuticals INC. | $21.16 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Kai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.